scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and ...
Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 millionCash and cash ...